Systems and methods for treating shoulder pain related to subacromial impingement syndrome
Systems and methods are provided for treating chronic pain occurring secondarily to subacromial impingement syndrome in a human body. A system is provided to deliver percutaneous electrical stimulation through at least one electrode to neurological motor points of the posterior and middle deltoid muscles to mediate such pain. One-time, continued and/or periodic dosing of treatment methods according to the present invention may result in a change to central nervous system maladaptive neuroplasticity.
1. An electrical stimulation system comprising:
an intramuscular lead;
at least one electrode insertable into a patient, the at least one electrode operatively coupled with the intramuscular lead;
an electrical stimulator operatively coupled with the intramuscular lead, wherein the electrical stimulator delivers electrical stimulation through the at least one electrode to produce a muscle contraction in a target area providing physiologic activation of muscle spindles and golgi tendon organs and afferent input to a central nervous system of the patient to treat pain.
2. The electrical stimulation system of claim 1 , wherein the at least one electrode is formed as part of the intramuscular lead.
3. The electrical stimulation system of claim 2 , wherein the at least one electrode extends from a conductor attached with the intramuscular lead.
4. The electrical stimulation system of claim 1 , wherein the lead includes a portion having an insulated body and the at least one electrode is formed from a portion of the intramuscular lead free of the insulated body.
5. The electrical stimulation system of claim 1 , wherein the electrical stimulator is external to the patient.
6. The electrical stimulation system of claim 1 , wherein the electrical stimulator is implanted in the patient.
7. The electrical stimulation system of claim 1 , wherein the intramuscular lead comprises an insulated coiled portion.
8. The electrical system of claim 1 further comprising an introducer needle configured to percutaneously insert the intramuscular lead.
9. The electrical system of claim 1 , wherein a parameter of the electrical stimulation delivered through the at least one electrode comprises a frequency of between 5 HZ and 25 HZ.
10. The electrical system of claim 1 , wherein a parameter of the electrical stimulation delivered through the at least one electrode comprises a pulse duration of between 20 microseconds and 200 microseconds.
11. The electrical system of claim 1 , wherein a parameter of the electrical stimulation delivered through the at least one electrode comprises an amplitude of between 0.1 mA and 20 mA.
12. The electrical system of claim 1 , wherein the at least one electrode comprises a single electrode.
13. An electrical stimulation system comprising:
an intramuscular lead;
an electrode insertable into subepidermal tissue of a patient, the electrode operatively coupled with the intramuscular lead;
an electrical stimulator operatively coupled with the intramuscular lead, wherein the electrical stimulator delivers electrical stimulation through the electrode to produce a muscle contraction in a target area providing physiologic activation of muscle spindles and golgi tendon organs and afferent input to a central nervous system of the patient to treat pain.
14. The electrical system of claim 13 , wherein a parameter of the electrical stimulation delivered through the electrode comprises a frequency of between 5 HZ and 25 HZ.
15. The electrical system of claim 14 , wherein a parameter of the electrical stimulation delivered through the electrode comprises a pulse duration of between 20 microseconds and 200 microseconds.
16. The electrical system of claim 15 , wherein a parameter of the electrical stimulation delivered through the electrode comprises an amplitude of between 0.1 mA and 20 mA.
17. The electrical stimulation system of claim 13 , wherein the electrical stimulator is external to the patient.
18. The electrical stimulation system of claim 13 , wherein the intramuscular lead comprises a coiled wire portion that is insulated.
19. The electrical system of claim 18 , wherein the electrode comprises an extension and a barb.
20. The electrical system of claim 19 , wherein the barb is angled relative to the extension of an angle of about 20 degrees to 70 degrees.
21. The electrical system of claim 20 further comprising a connector electrically and operatively connecting the lead with the electrical stimulator.
22. An electrical stimulation system comprising:
an intramuscular lead at least a portion of which is positionable into subepidermal tissue of a patient;
an electrode extending from a distal end of the intramuscular lead, the electrode comprising an uninsulated portion of the intramuscular lead;
an electrical stimulator operatively coupled with the intramuscular lead, wherein the electrical stimulator delivers electrical stimulation through the electrode to produce a muscle contraction in a target area providing physiologic activation of muscle spindles and golgi tendon organs to treat pain.
23. The electrical stimulation system of claim 22 , wherein the electrical stimulator comprises a user mode and a clinician mode.
24. The electrical stimulation system of claim 23 , wherein the user mode comprises a predetermined number of stimulus intensities.
25. The electrical stimulation system of claim 23 , wherein the clinician mode permits programming of parameters of the electrical stimulation, displays usage information and errors.
26. The electrical stimulation system of claim 23 , wherein the clinician mode allows for programming of minimum pulse duration, normal pulse duration and maximum pulse duration for the electrical stimulation.